Clinical Trial Update: Induction of Clinical Response Using Rifaximin in Crohn's Disease [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating rifaximin for induction of clinical response in Crohn's disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease

Drugs mentioned

• Rifaximin (rifaximin)

Snippet

Sponsor: Scott Lee | Conditions: Crohn's Disease | Phase 2 | Status: COMPLETED